EUROFINS SCIENT Current Ratio 2018-2025 | ERFSF
Current and historical current ratio for EUROFINS SCIENT (ERFSF) from 2018 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. EUROFINS SCIENT current ratio for the three months ending June 30, 2025 was 0.00.
| EUROFINS SCIENT Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-06-30 | $2.97B | $2.37B | 1.26 |
| 2024-12-31 | $2.65B | $2.28B | 1.16 |
| 2024-06-30 | $2.81B | $1.98B | 1.42 |
| 2023-06-30 | $2.82B | $1.97B | 1.44 |
| 2022-12-31 | $2.44B | $1.87B | 1.31 |
| 2021-12-31 | $2.74B | $2.20B | 1.25 |
| 2021-06-30 | $2.91B | $2.12B | 1.37 |
| 2020-12-31 | $2.88B | $1.94B | 1.48 |
| 2020-06-30 | $2.13B | $1.56B | 1.36 |
| 2019-12-31 | $1.80B | $1.77B | 1.01 |
| 2019-06-30 | $1.76B | $2.26B | 0.78 |
| 2018-12-31 | $2.01B | $1.71B | 1.18 |
| 2018-06-30 | $1.96B | $1.76B | 1.12 |
| 2017-12-31 | $2.07B | $1.64B | 1.26 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $15.053B | $7.522B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $149.662B | 27.76 |
| CVS Health (CVS) | United States | $88.998B | 11.07 |
| Elevance Health (ELV) | United States | $69.652B | 9.37 |
| Cencora (COR) | United States | $56.292B | 18.74 |
| DiDi Global (DIDIY) | China | $26.968B | 28.65 |
| Labcorp Holdings (LH) | United States | $22.478B | 17.87 |
| Natera (NTRA) | United States | $22.118B | 0.00 |
| BioMerieux (BMXMF) | France | $17.991B | 0.00 |
| ICON (ICLR) | Ireland | $14.420B | 13.87 |
| Medpace Holdings (MEDP) | United States | $13.005B | 34.42 |
| CochLear (CHEOY) | Australia | $12.576B | 0.00 |
| Viatris (VTRS) | United States | $12.393B | 4.41 |
| Solventum (SOLV) | United States | $12.269B | 12.66 |
| Revvity (RVTY) | United States | $10.411B | 18.34 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.110B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.247B | 0.00 |
| Avantor (AVTR) | United States | $8.699B | 12.76 |
| HealthEquity (HQY) | United States | $7.742B | 33.91 |
| Charles River Laboratories (CRL) | United States | $7.726B | 14.66 |
| Bausch + Lomb (BLCO) | Canada | $5.119B | 34.43 |
| Sotera Health (SHC) | United States | $4.488B | 25.08 |
| BrightSpring Health Services (BTSG) | United States | $4.090B | 31.20 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.617B | 82.83 |
| Alignment Healthcare (ALHC) | United States | $3.028B | 0.00 |
| Concentras Parent (CON) | United States | $2.931B | 18.59 |
| Surgery Partners (SGRY) | United States | $2.883B | 36.27 |
| Organon (OGN) | United States | $2.412B | 2.63 |
| Progyny (PGNY) | United States | $2.045B | 43.24 |
| Premier (PINC) | United States | $2.012B | 15.27 |
| Ardent Health (ARDT) | United States | $1.806B | 6.97 |
| GoodRx Holdings (GDRX) | United States | $1.779B | 30.12 |
| PACS (PACS) | United States | $1.739B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.393B | 9.30 |
| Teladoc Health (TDOC) | United States | $1.323B | 0.00 |
| Omada Health (OMDA) | $1.204B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.108B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.788B | 4.62 |
| AMN Healthcare Services Inc (AMN) | United States | $0.745B | 9.21 |
| CareDx (CDNA) | United States | $0.631B | 11.62 |
| Performant Healthcare (PHLT) | United States | $0.601B | 0.00 |
| Nutex Health (NUTX) | United States | $0.525B | 7.95 |
| QDM (QDMI) | Hong Kong, SAR China | $0.525B | 90.00 |
| Agilon Health (AGL) | United States | $0.510B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.477B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.477B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.462B | 10.40 |
| SBC Medicals (SBC) | United States | $0.439B | 9.64 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.409B | 0.00 |
| Enhabit (EHAB) | United States | $0.404B | 26.57 |
| So-Young (SY) | China | $0.367B | 0.00 |
| Oncology Institute (TOI) | United States | $0.361B | 0.00 |
| LifeMD (LFMD) | United States | $0.309B | 0.00 |
| Beauty Health (SKIN) | United States | $0.278B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.218B | 0.00 |
| DocGo (DCGO) | United States | $0.164B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.137B | 0.00 |
| KindlyMD (NAKA) | United States | $0.091B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.039B | 0.00 |
| ModivCare (MODV) | United States | $0.035B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.023B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |